Resources

Delve into the wealth of information on P. vivax malaria through our dedicated resources page. This section features fact sheets, guidance documents, peer-reviewed articles and strategies on P. vivax malaria. Contact us if you have relevant peer-reviewed information that would be useful for the P. vivax malaria community.

1
22 Sep 2023

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

The Lancet Infectious Diseases
Peer-reviewed article
20 Sep 2023

George Jagoe, MMV Executive Vice President, at MedTrop 2023

On September 10, MMV and PATH, co-leads of the Partnership for Vivax Elimination (PAVE) Consortium, co-hosted a panel with the Brazilian Ministry of Health at the Brazilian Society of Tropical Medicine Congress. Watch George Jaogoe, Executive Vice-President for Access & Product Management at MMV, discuss the implementation of tafenoquine and the Standard G6PD test in the country's health system and what it means for other countries in the region.
Videos
20 Sept 2023

Treating Plasmodium vivax malaria in Brazil

As of June 6, 2023, Brazil marked a significant milestone by becoming the first malaria-endemic country to incorporate single-dose tafenoquine and the STANDARD (TM) G6PD test for P. vivax malaria. Following the decision by the Unified Health System's National Commission of New Health Technologies Incorporation (CONITEC) to adopt this innovative treatment, Brazil's Ministry of Health is now leading technical discussions to plan and prepare the health system for nationwide implementation. Dr Marcus Lacerda, the Principal Investigator of the Tafenoquine Roll-oUt STudy (TRuST) study, which generated crucial evidence to inform CONITEC’s decision, highlighted the significance of these new tools for Brazil, particularly their impact on the most at-risk populations.
Videos
19 Sep 2023

Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening

This study reviews five events of acute haemolytic anaemia following the administration of primaquine in four malaria trials from Indonesia, the Solomon Islands, and Vietnam.
Pathogens
Peer-reviewed article
front cover of factsheet
18 Sep 2023

The Tafenoquine Rollout Study (TRuST) Factsheet, September 2023

An overview of the Tafenoquine Rollout Study, (TRuST) conducted in Brazil in 2021 and 2022, co-sponsored by the Ministry of Health and Medicines for Malaria Venture (MMV).
The Partnership for Vivax Elimination (PAVE)
Fact sheet
front page of factsheet
18 Sep 2023

PAVE in Brazil: Evidence to inform Public Policies

A factsheet introducing the work of the Partnership for Vivax Elimination PAVE) in Brazil from 2018 to 2023.
The Partnership for Vivax Elimination (PAVE)
Fact sheet
Poster with speakers
15 Sep 2023

Exploring Safety of Higher Doses of Primaquine: Advancing Towards Vivax Elimination| APMEN TechTalks

This TechTalk webinar presented recent research and a meta-analysis on primaquine safety and identified what additional evidence is required for a shorter course, higher dose of primaquine.
APMEN Vivax Working Group (VxWG)
Videos
Front cover of the resource
01 Aug 2023

Regional Vivax Radical Cure Counseling Guide (Mekong)

The purpose of this regional guide is to equip National Malaria Program (NMP) and Civil Society Organization (CSO) leaders across the Greater Mekong Subregion to use best practices related to community level counseling to promote treatment adherence and care for side effects among patients diagnosed with P. vivax.
Malaria Free Mekong
Toolkits and Training
Front page of report
05 Jun 2023

Recommendation report number 832: Tafenoquine and quantitative test for glucose-6-phosphate dehydrogenase (G6PD) enzyme activity for treating patients with Plasmodium vivax malaria

Recommendation report number 832: Tafenoquine and quantitative test for glucose-6-phosphate dehydrogenase (G6PD) enzyme activity for treating patients with Plasmodium vivax malaria. Available in Portuguese only.

CONITEC:
Policy
23 May 2023

Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study

The Lancet Infectious Diseases
Peer-reviewed article
08 May 2023

Assessing the Operational Feasibility of Integrating Point-of-Care G6PD Testing into Plasmodium vivax Malaria Management in Vietnam

Plasmodium vivax cases represent more than 50% of a diminishing malaria case load in Vietnam. Safe and effective radical cure strategies could support malaria elimination by 2030. This study investigated the operational feasibility of introducing point-of-care quantitative glucose-6-phosphate dehydrogenase (G6PD) testing into malaria case management practices. 

Pathogens
Peer-reviewed article
28 Apr 2023

"Hacia la Eliminación de la Malaria" 2023

Ministry of Health Peru (MINSA)
Videos

Pages